Results 211 to 220 of about 8,424 (263)

Two Strikes: A Case Study of Consecutive St-Elevation Myocardial Infarctions (Stemi) in two Different Coronary Arteries. [PDF]

Eur J Case Rep Intern Med
Chirumamilla Y, Chinnappan J, Alkotob ML.   +2 more
europepmc   +1 more source

Producing highly effective extracellular vesicles using IBAR and talin F3 domain fusion. [PDF]

Anim Cells Syst (Seoul)
Lee J, Lee M, Kim J, Cho EG, Kim C.
europepmc   +1 more source

Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency. [PDF]

Res Pract Thromb Haemost
Del Carpio-Cano F, Songdej N, Guan L, Mao G, Goldfinger LE, Wurtzel JGT, Lee K, Lambert MP, Poncz M, Rao AK.   +9 more
europepmc   +1 more source

Managing thrombosis risk in flow diversion: A review of antiplatelet approaches.

Neuroradiol J
Toma A, Essibayi MA, Osama M, Karandish A, Dmytriw AA, Altschul D.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Delayed-onset eptifibatide-induced thrombocytopenia.

American Journal of Health-System Pharmacy, 2023
DISCLAIMER In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and ...
Travis Huffman, Evan Gleaves, Glee Lenoir, Rahil Rafeedheen   +3 more
semanticscholar   +3 more sources

Complications and Management of Eptifibatide-Induced Thrombocytopenia

Annals of Pharmacotherapy, 2021
Background Eptifibatide is used in acute coronary syndromes to reversibly block platelet aggregation by inhibiting the platelet glycoprotein IIb/IIIa receptor.
F. Masood, Saad Hashmi, A. Chaus, Anna Hertsberg, E. Ehrenpreis   +4 more
semanticscholar   +5 more sources

Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke.

New England Journal of Medicine
BACKGROUND Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide (an antiplatelet agent) are unclear. METHODS We
O. Adeoye, Joseph P Broderick, C. P. Derdeyn, James Grotta, W. Barsan, Oladi Bentho, Scott Berry, Mauricio Concha, Iris Davis, S. Demel, Jordan Elm, Nina Gentile, Todd Graves, Melissa Hoffman, Josephine Huang, James Ingles, Scott Janis, Adam S Jasne, Pooja Khatri, Steven R Levine, A. Majjhoo, Peter Panagos, A. Pancioli, Stephanie Pizzella, Tamra Ranasinghe, Noor Sabagha, Sanjeev Sivakumar, Christopher Streib, A. Vagal, Alastair Wilson, M. Wintermark, A. Yoo, A. Barreto   +32 more
semanticscholar   +3 more sources

Safety and efficacy of eptifibatide in acute ischemic stroke requiring extracranial carotid artery stenting.

Interventional Neuroradiology, 2023
BACKGROUND The antiplatelet management in acute ischemic stroke requiring carotid artery stenting is heterogenous, with no clear guidelines to direct management.
M. Waters, J. Vargas, A. Turk, I. Chaudry, R. Turner   +4 more
semanticscholar   +1 more source